Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET) Receivables (2016 - 2026)

Metlife's Receivables history spans 18 years, with the latest figure at $53.4 billion for Q1 2026.

  • Quarterly Receivables rose 56.29% to $53.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $53.4 billion through Mar 2026, up 56.29% year-over-year, with the annual reading at $49.1 billion for FY2025, 50.86% up from the prior year.
  • Receivables came in at $53.4 billion for Q1 2026, up from $52.0 billion in the prior quarter.
  • In the past five years, Receivables ranged from a high of $53.4 billion in Q1 2026 to a low of $394.0 million in Q1 2022.
  • The 5-year median for Receivables is $21.5 billion (2023), against an average of $26.0 billion.
  • Year-over-year, Receivables crashed 97.92% in 2022 and then skyrocketed 6098.91% in 2025.
  • Metlife's Receivables stood at $19.8 billion in 2022, then soared by 59.28% to $31.6 billion in 2023, then rose by 3.13% to $32.6 billion in 2024, then surged by 59.64% to $52.0 billion in 2025, then rose by 2.73% to $53.4 billion in 2026.
  • Per Business Quant, the three most recent readings for MET's Receivables are $53.4 billion (Q1 2026), $52.0 billion (Q4 2025), and $43.3 billion (Q3 2025).